当前位置: 首页 > 期刊 > 《上海医药》 > 2014年第15期
编号:12647762
中英两国对中医药研发创新认识差异的访谈分析(1)
http://www.100md.com 2014年8月1日 上海医药 2014年第15期
     摘 要 本文基于在英国的访谈分析,认为中药毒理是研发的重要领域,基于众包的全国中医病例系统是研发的重要基础,中药产业政策的失误给中药创新带来了损害。加强中央政府顶层设计、推动中医药全球众包研发平台的建立是提升我国中药创新研究的重要途径。

    关键词 中药创新 中药毒理 中英认识差异 众包创新

    中图分类号:R288 文献标识码:C 文章编号:1006-1533(2014)15-0063-03

    Interview analysis of Sino-British different

    concepts on traditional Chinese medicine innovation*

    LI Jianguo**

    (School of Economics and Management, Guangzhou University of Chinese Medicine, Guangzhou 510006, China)

    ABSTRACT The pharmacology of traditional Chinese medicine (TCM) is considered as an important field in research and development based on the analysis of the interview in the United Kingdom and the system of national TCM cases as the foundation of research and development in TCM based on crowdsourcing innovation. The mistakes of the industrial policy on TCM may result in the damage to TCM innovation. Strengthening the top-level design of central government and promoting the establishment of a platform for the research and development in the pharmaceutical global crowdsourcing are essential to improve TCM innovation. ......
1 2下一页

您现在查看是摘要页,全文长 4183 字符